Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies - Image 1

£120.94

Springer Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Name: Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies
Brand: Springer
Price: 120.94 GBP
Availability: InStock

International

It has never been this cheap. We have no record of a lower price.

£121 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 69 days • 1 price levels

Days at Price

Price Analysis

Most common price: £121 (69 days, 100.0%)

Price range: £121 - £121

Price levels: 1 different prices over 69 days

Description

The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibilities for the treatment of hereditary diseases in humans. The treatment of such often severe but hitherto uncurable diseases can be based on genome-edited induced pluripotent stem cells (iPS cells). Such treatments constitute combined cell/gene therapies. These therapies need to be governed by a regulatory framework which ensures quality, safety, and efficacy of the relevant therapeutic products. On the other hand, such regulations may retard product approval and impede R&D. Accordingly, national regulations for therapies based on genome-edited iPS cells are an important and, as the case may be, decisive factor for both researchers and industry regarding their decision where to locate their R&D activities. Therefore, regulatory frameworks impact significantly on the competitiveness of states and their economies. This is why a comparative analysis of laws and regulations of different countries matters. Such a comparative legal analysis provides an important insight into regulatory concepts which, in turn, may inspire adjustments of, or amendments to, domestic legal regimes. For this purpose, experts present country reports on France, Germany, Japan, South Korea, Switzerland, and the USA. The reports on France and Germany also refer to the parameters and implications arising from pertinent EU law. This contributed volume is aimed at researchers, but also at, e.g., legal scholars, lawmakers, regulators, and political decision makers.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3030930254
Category: Books > Subjects > Business, Finance & Law > Law > International
Domain: Amazon UK
Release Date: 25 May 2023
Listed Since: 27 April 2023

Barcode

No barcode data available

Springer Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization: 1353 (Methods in Molecular Biology, 1353)

Induced Pluripotent Stem (iPS) Cells: Methods and Protocols: 1357 (Methods in Molecular Biology, 1357)

Induced Pluripotent Stem (iPS) Cells: Methods and Protocols: 1357 (Methods in Molecular Biology, 1357)

Human Embryonic and Induced Pluripotent Stem Cells: Lineage-Specific Differentiation Protocols (Springer Protocols Handbooks)

Stem Cell Epigenetics (Volume 17) (Translational Epigenetics, Volume 17)

Rechtliche Herausforderungen moderner Verfahren der Intervention in die menschliche Keimbahn: CRISPR/Cas9, hiPS-Zellen und Mitochondrientransfer im ... Universitäten Heidelberg und Mannheim, 49)

Pluripotent Stem Cells: Methods and Protocols: 997 (Methods in Molecular Biology, 997)

RNAi and microRNA-Mediated Gene Regulation in Stem Cells: Methods, Protocols, and Applications: 650 (Methods in Molecular Biology, 650)

Engineering and Application of Pluripotent Stem Cells: 163 (Advances in Biochemical Engineering/Biotechnology, 163)

Human Pluripotent Stem Cells: Methods and Protocols: 767 (Methods in Molecular Biology, 767)

Humana Stem Cell Transcriptional Networks Methods and Protocols

Translational Stem Cell Research: Issues Beyond the Debate on the Moral Status of the Human Embryo (Stem Cell Biology and Regenerative Medicine)

Stem Cells and Cancer Stem Cells, Volume 4: Therapeutic Applications in Disease and Injury

Mammalian Cell Engineering: Methods and Protocols: 2312 (Methods in Molecular Biology, 2312)

Epiblast Stem Cells: Methods and Protocols: 1074 (Methods in Molecular Biology, 1074)

Transcriptional and Translational Regulation of Stem Cells: 786 (Advances in Experimental Medicine and Biology, 786)

Animal Transgenesis and Cloning

Reshaping Healthcare with Cutting-Edge Biomedical Advancements

Transgenic Animals: Principles and Development

Biotechnology Law and Policy: Emerging Legal Issues, Cases and Materials

Stem Cells and Cancer Stem Cells, Volume 2: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 2

Embryonic Stem Cell Immunobiology: Methods and Protocols: 1029 (Methods in Molecular Biology, 1029)